13th March 2017
1st March 2017
1st December 2016
Arquer Diagnostics and the University of Sunderland collaborate to extend application of cancer diagnostic
17th October 2016
Simple, Non-invasive Diagnostics
Arquer Diagnostics is focused on the development and commercialisation of highly accurate minichromosome maintenance (MCM) protein based non-invasive tests for cancer diagnosis and monitoring from small amounts of body fluid.
Arquer aim to meet demand expressed by patients, clinicians and payers for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes.
MCM5 Proteins are excellent cancer biomarkers because:
- They are robustly expressed in dividing cells and those preparing to divide
- MCM proteins are not expressed in fully differentiated cells
- When a mass of replicating cells, such as a bladder tumour, is present MCM positive cells are shed into the body fluids
- MCM positive cells are not usually present in the body fluids in the absence of cancer or damage